SmarterDividends
NONOF

Novo Nordisk A/S

NONOF

Healthcare · Stock · semiannual payer

$46.50

Undervalued · +56% Add to Portfolio

Forward Yield

2.64%

Annual Dividend

$11.70

Payout Ratio

5-Yr Growth

28.5%

Ex-Date

Frequency

Semiannual

Summary

As of September 2026, Novo Nordisk A/S (NONOF) yields 2.64% ($11.70 per share annually), with a blended fair-value estimate of $70.44 — +56% upside, so it screens as undervalued. Dividend safety grade: C (58/100). 6 years of dividend growth.

Is NONOF a good dividend stock?

Yes, with caveats

Novo Nordisk A/S (NONOF) pays a semiannual dividend yielding 2.64% ($11.70/yr), with 6 years of growth and a dividend-safety grade of C. It's a solid income payer, but check the caveats below before buying.

Advantages

  • Strong 28.5% 5-yr dividend growth

Risks

  • Cut its dividend in 2017
  • Share price is down over the past 5 years

Key Data

Dividend Yield
2.64%
Payout Ratio
Annual Dividend
$11.70
5-Yr Avg Growth
28.5%
Ex-Dividend Date
Years of Growth
6
Frequency
semiannual
Beta
0.35
Market Cap
$205.6B
P/E Ratio
11.4
5-Yr Total Return
-6%
52-Week Range
$34.00 – $64.75
Dividend Safety
C · 58/100
Ever Cut?
Yes (2017)
NONOF ex-dividend date & scheduleNext ex-date · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $11.70 / yr per share

Per payment (semiannual)$585.00
Annual$1,170.00
Monthly avg$97.50